Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer
Journal of Medicinal Chemistry · 09.04.2026 · 69 (7) · 8075-8093
DOI: 10.1021/acs.jmedchem.5c03442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 20.03.2026. Verfasst von Chaofan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Moderni…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Prostatic Neoplasms, Castration-Resistant, Retinoid X Receptors, Drug Discovery. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Sun Yat-sen University, Guangzhou Medical University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education,…
- Guangdong Engineering Technology Research Center of Urinary Continence and Reproductive Medicine, the Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, Guangdong 511500,…
- National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, China.
- State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou, Guangdong 510006, China.
- Department of Hematology, Guangdong Second Provincial General Hospital, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Zhanfang Kang, Yang Zhou, Xiaoyun Lu
Förderung
- Sun Yat-sen University
- Guangzhou Medical University
- National Key Research and Development Program of China
- Changjiang Scholar Program, Ministry of Education
- Basic and Applied Basic Research Foundation of Guangdong Province
- Jinan University
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Lin, J., Pei, J., Kang, Z., Liu, Z., Li, J., Cai, G., Zhou, Y., Wang, J., Wang, H., & Lu, X. (2026). Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer. Journal of Medicinal Chemistry, 69(7), 8075-8093. https://doi.org/10.1021/acs.jmedchem.5c03442
Vancouver
Wang C, Lin J, Pei J, Kang Z, Liu Z, Li J, et al. Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer. Journal of Medicinal Chemistry. 2026;69(7):8075-8093. doi:10.1021/acs.jmedchem.5c03442
BibTeX
@article{Wang2026,
author = {Wang, Chaofan and Lin, Jieying and Pei, Junping and Kang, Zhanfang and Liu, Zhuoheng and Li, Junwei and Cai, Guodi and Zhou, Yang and Wang, Junjian and Wang, Hong and Lu, Xiaoyun},
title = {Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {7},
pages = {8075--8093},
doi = {10.1021/acs.jmedchem.5c03442}
}
EUVIMED